Keywords: Roche, Avastin, mCRC, Colorectal cancer, Novartis, Exjade, Iron overload, Thalassemia, USA, FDA

FDA clears new use for Roche's Avastin and Novartis' Exjade

Article | 25 January 2013

Print This

The US Food and Drug Administration has approved a new use for Swiss drug major Roche’s (ROG: SIX) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in